CL2018000033A1 - Composición para destapar una nariz tapada que tiene actividad antiviral. - Google Patents
Composición para destapar una nariz tapada que tiene actividad antiviral.Info
- Publication number
- CL2018000033A1 CL2018000033A1 CL2018000033A CL2018000033A CL2018000033A1 CL 2018000033 A1 CL2018000033 A1 CL 2018000033A1 CL 2018000033 A CL2018000033 A CL 2018000033A CL 2018000033 A CL2018000033 A CL 2018000033A CL 2018000033 A1 CL2018000033 A1 CL 2018000033A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- uncover
- carragenine
- ionic
- antiviral activity
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002727 hyperosmolar Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
LLA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA QUE TIENE UNA ACTIVIDAD PARA DESTAPAR UNA NARIZ TAPADA, CARACTERIZADA PORQUE LA COMPOSICIÓN COMPRENDE UNA SOLUCIÓN ACUOSA HIPEROSMOLAR DE UN AGENTE DE AJUSTE DE LA OSMOLALIDAD NO IÓNICA, OPCIONALMENTE EN COMBINACIÓN CON UN AGENTE DE AJUSTE DE LA OSMOLALIDAD IÓNICA, DONDE LA COMPOSICIÓN COMPRENDE ADEMÁS IOTA -CARRAGENINA Y / O KAPPA-CARRAGENINA COMO INGREDIENTE ANTIVIRAL ACTIVO EN UNA CANTIDAD ANTIVIRALMENTE EFICAZ, CON LA CONDICIÓN DE QUE LA COMPOSICIÓN EN SU FORMULACIÓN LISTA PARA USAR CONTENGA NO MÁS DE 0 - 1,5% P / V DEL AGENTE DE AJUSTE DE LA OSMOLALIDAD IÓNICA. LA COMPOSICIÓN ES ÚTIL PARA DESTAPAR UNA NARIZ TAPADA Y PARA LA INTERVENCIÓN PROFILÁCTICA O TERAPÉUTICA DE VARIAS INFECCIONES VIRALES DEL TRACTO RESPIRATORIO SUPERIOR.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15176670 | 2015-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018000033A1 true CL2018000033A1 (es) | 2018-08-10 |
Family
ID=53717900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018000033A CL2018000033A1 (es) | 2015-07-14 | 2018-01-05 | Composición para destapar una nariz tapada que tiene actividad antiviral. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10660914B2 (es) |
| EP (1) | EP3370692B1 (es) |
| JP (1) | JP6774435B2 (es) |
| KR (1) | KR102628781B1 (es) |
| CN (1) | CN107847430B (es) |
| AU (1) | AU2016293004B2 (es) |
| BR (1) | BR112018000592B1 (es) |
| CA (1) | CA2992352C (es) |
| CL (1) | CL2018000033A1 (es) |
| DK (1) | DK3370692T3 (es) |
| EA (1) | EA037085B1 (es) |
| ES (1) | ES2949139T3 (es) |
| FI (1) | FI3370692T3 (es) |
| HU (1) | HUE062108T2 (es) |
| IL (1) | IL256883B (es) |
| LT (1) | LT3370692T (es) |
| MA (1) | MA43155A (es) |
| MX (1) | MX372625B (es) |
| MY (1) | MY194870A (es) |
| NZ (1) | NZ738597A (es) |
| PH (1) | PH12018500044B1 (es) |
| PL (1) | PL3370692T3 (es) |
| PT (1) | PT3370692T (es) |
| SA (1) | SA518390689B1 (es) |
| WO (1) | WO2017009351A1 (es) |
| ZA (1) | ZA201708595B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201806835SA (en) * | 2016-02-17 | 2018-09-27 | Ent Tech Pty Ltd | Compositions and methods for the treatment of sinus disease and disorders |
| GB2567285A (en) * | 2017-08-07 | 2019-04-10 | Suprapharm Cc | Preparation for nasal-nasopharyngeal treatment |
| JP2023517239A (ja) | 2020-03-12 | 2023-04-24 | デイヴィッド カリス－ヒル、シドニー | コロナウイルス感染症および関連するサイトカイン毒性の治療 |
| CN111437270A (zh) * | 2020-04-24 | 2020-07-24 | 瑞希(重庆)生物科技有限公司 | 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法 |
| US11013687B1 (en) * | 2020-06-08 | 2021-05-25 | Amcyte Pharma, Inc. | Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2 |
| CN111686125A (zh) * | 2020-06-18 | 2020-09-22 | 大连工业大学 | 卡拉胶在抗新型冠状病毒中的应用 |
| WO2021253643A1 (zh) * | 2020-06-18 | 2021-12-23 | 大连工业大学 | 硫酸化多糖在抗新型冠状病毒中的应用 |
| MX2022016267A (es) * | 2020-06-22 | 2023-03-31 | Mario Elmen Tremblay | Lubricantes personales que comprenden lambda-carragenina. |
| EP3939597A1 (en) | 2020-07-16 | 2022-01-19 | Marinomed Biotech AG | Antiviral pharmaceutical composition comprising a carrageenan component |
| CN116249515A (zh) * | 2020-08-04 | 2023-06-09 | 科斯莫索弗特公司 | 用于通过鼻腔途径治疗covid-19疾病的呼吸道症状的包含甘油和卡波姆的水凝胶 |
| FR3113237B1 (fr) | 2020-08-04 | 2023-06-09 | Biopass | Produit pour le traitement de maladies virales par voie nasale |
| DE202020004186U1 (de) * | 2020-10-05 | 2020-10-21 | Christian Fleischhammel | Antiinfektive Arzneiform zur Herstellung einer Nasenspülung gegen COVID-19 |
| EP3991561A1 (en) * | 2020-10-28 | 2022-05-04 | Vepidan ApS | Antimicrobial disinfectant gel |
| GB202109888D0 (en) | 2021-07-08 | 2021-08-25 | Pollinner Ltd | Nasal spray |
| KR102720037B1 (ko) * | 2021-12-21 | 2024-10-22 | (주)메디코어 | 비강 세정제 조성물 및 그 제조방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2653021A1 (fr) * | 1989-10-17 | 1991-04-19 | Merck Sharp & Dohme | Composition ophtalmique aqueuse liquide a transition de phase liquide-gel. |
| US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
| LT2522365T (lt) * | 2004-11-24 | 2017-02-10 | Meda Pharmaceuticals Inc. | Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai |
| US20080241271A1 (en) * | 2006-11-08 | 2008-10-02 | Roman Stephen B | Foaming anti-adhesion composition |
| EA015930B1 (ru) | 2006-12-05 | 2011-12-30 | Мариномед Биотехнологи Гмбх | Применение йота-каррагинана для лечения риновирусной инфекции и фармацевтическая композиция для лечения риновирусной инфекции, содержащая йота-каррагинан |
| JP4941977B2 (ja) * | 2007-04-11 | 2012-05-30 | 大蔵製薬株式会社 | ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物 |
| BRPI0815748B8 (pt) * | 2007-08-24 | 2021-05-25 | Marinomed Biotechnologie Gmbh | uso de iota-carragenina em uma quantidade antiviral eficaz |
| WO2009060915A1 (ja) * | 2007-11-06 | 2009-05-14 | San-Ei Gen F.F.I., Inc. | 唾液分泌促進剤 |
| FR2926218B1 (fr) * | 2008-01-10 | 2010-08-13 | Galderma Res & Dev | Composition comprenant un retinoide et du peroxyde de benzoyle disperse. |
| WO2013049538A1 (en) * | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | Allergen nasal compositions |
-
2016
- 2016-07-12 MX MX2018000285A patent/MX372625B/es active IP Right Grant
- 2016-07-12 FI FIEP16738419.7T patent/FI3370692T3/fi active
- 2016-07-12 AU AU2016293004A patent/AU2016293004B2/en active Active
- 2016-07-12 KR KR1020187004269A patent/KR102628781B1/ko active Active
- 2016-07-12 WO PCT/EP2016/066565 patent/WO2017009351A1/en not_active Ceased
- 2016-07-12 NZ NZ738597A patent/NZ738597A/en unknown
- 2016-07-12 MA MA043155A patent/MA43155A/fr unknown
- 2016-07-12 PL PL16738419.7T patent/PL3370692T3/pl unknown
- 2016-07-12 DK DK16738419.7T patent/DK3370692T3/da active
- 2016-07-12 CN CN201680039448.1A patent/CN107847430B/zh active Active
- 2016-07-12 PH PH1/2018/500044A patent/PH12018500044B1/en unknown
- 2016-07-12 BR BR112018000592-4A patent/BR112018000592B1/pt active IP Right Grant
- 2016-07-12 HU HUE16738419A patent/HUE062108T2/hu unknown
- 2016-07-12 ES ES16738419T patent/ES2949139T3/es active Active
- 2016-07-12 EA EA201890196A patent/EA037085B1/ru unknown
- 2016-07-12 CA CA2992352A patent/CA2992352C/en active Active
- 2016-07-12 MY MYPI2017704939A patent/MY194870A/en unknown
- 2016-07-12 JP JP2017565990A patent/JP6774435B2/ja active Active
- 2016-07-12 PT PT167384197T patent/PT3370692T/pt unknown
- 2016-07-12 LT LTEPPCT/EP2016/066565T patent/LT3370692T/lt unknown
- 2016-07-12 US US15/767,273 patent/US10660914B2/en active Active
- 2016-07-12 EP EP16738419.7A patent/EP3370692B1/en active Active
-
2017
- 2017-12-18 ZA ZA2017/08595A patent/ZA201708595B/en unknown
-
2018
- 2018-01-03 SA SA518390689A patent/SA518390689B1/ar unknown
- 2018-01-05 CL CL2018000033A patent/CL2018000033A1/es unknown
- 2018-01-11 IL IL256883A patent/IL256883B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018000033A1 (es) | Composición para destapar una nariz tapada que tiene actividad antiviral. | |
| NI201400842A (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas. | |
| CL2020000739A1 (es) | Agente prolongado de control de ectoparasito para animales. | |
| MX2022014313A (es) | Formulaciones para administracion oral de agentes activos con perfil de absorcion controlada. | |
| BR122021018243A8 (pt) | Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável | |
| MX387788B (es) | Uso de agentes activos durante tratamientos quimicos. | |
| AR104212A1 (es) | Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismas | |
| BR112013018920A2 (pt) | composições de nanopartículas, formulações destas e seus usos | |
| TR201904455T4 (tr) | Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları. | |
| AR103803A1 (es) | Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas | |
| BR112019004496A2 (pt) | estabilizantes de mastócitos para tratamento de hipercitocinemia e infecção viral | |
| MX2017013141A (es) | Composicion farmaceutica para la prevencion y/o tratamiento de dermatitis atopica que comprende antagonista de interleucina 31 (il-31) como ingrediente activo. | |
| MX2020006309A (es) | Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis. | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| WO2016044839A3 (en) | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds | |
| CO2020002624A2 (es) | Formulación de uso tópico para el control y la prevención de parásitos en animales | |
| WO2015081904A3 (en) | Polyurethaneurea solutions for compositions with active ingredients or fragrances | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| BR112017016278A2 (pt) | agente preventivo e/ou terapêutico de doença imune | |
| MX2017011040A (es) | Agente para el tratamiento de infeccion respiratoria. | |
| WO2014137231A3 (en) | Totarol extract formulations and uses thereof | |
| AR100850A1 (es) | Composición farmacéutica que comprende desmopresina y un agente estabilizador | |
| PE20242218A1 (es) | Composicion topica que comprende un extracto de ophiopogon para uso en el tratamiento de los parpados o el contorno del ojo | |
| NZ753294A (en) | Antimicrobial formulations for the improved treatment of veterinary hoof infections |